Leiomyosarcoma and Pancytopenia

Summary:

Pancytopenia is found among people with Leiomyosarcoma, especially for people who are female, 60+ old.

The study analyzes which people have Pancytopenia with Leiomyosarcoma. It is created by eHealthMe based on reports of 32 people who have Leiomyosarcoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Leiomyosarcoma?

Leiomyosarcoma (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue) is found to be associated with 27 drugs and 163 conditions by eHealthMe. Check the latest studies of Leiomyosarcoma.

What is Pancytopenia?

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 1,791 drugs and 2,431 conditions by eHealthMe. Check the latest studies of Pancytopenia.

On Aug, 04, 2026

32 people who have Leiomyosarcoma and Pancytopenia are studied.

Would you have Pancytopenia when you have Leiomyosarcoma?

Gender of people who have Leiomyosarcoma and experienced Pancytopenia *:

female: 73.33 %
male: 26.67 %

Age of people who have Leiomyosarcoma and experienced Pancytopenia *:

Common co-existing conditions for these people *:

Uterine Leiomyosarcoma (uterus cancer of smooth muscle connective tissue): 4 people, 12.50%
Metastases To Lung (cancer spreads to lung): 4 people, 12.50%
Leiomyosarcoma Metastatic (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue spreading to other parts): 3 people, 9.38%
Oedema (fluid collection in tissue): 2 people, 6.25%
Nausea (feeling of having an urge to vomit): 2 people, 6.25%
High Blood Pressure: 2 people, 6.25%
Breast Infection: 2 people, 6.25%

Common drugs taken by these people *:

Common symptoms for these people *:

Acute Kidney Failure: 11 people, 34.38%
Hepatic Function Abnormal: 11 people, 34.38%
Fever: 8 people, 25.00%
Renal Impairment (severely reduced kidney function): 6 people, 18.75%
Hepatic Failure (liver failure): 6 people, 18.75%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 6 people, 18.75%
Hyperbilirubinaemia (excess of bilirubin in the blood): 5 people, 15.62%
Tumor Lysis Syndrome: 5 people, 15.62%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 12.50%
Nausea (feeling of having an urge to vomit): 4 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Pancytopenia?

- Check whether Pancytopenia is associated with a drug or a condition

Related publications that referenced our studies

Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .

Related studies:

Treatments, associated drugs and conditions:

Leiomyosarcoma (1,537 reports)
Pancytopenia (69,290 reports)

All the drugs that are associated with Pancytopenia:

Pancytopenia (1,791 drugs)

All the conditions that are associated with Pancytopenia:

Pancytopenia (2,431 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Pancytopenia and Leiomyosarcoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.